AP Biosciences Inc (TPEX:6945)
Taiwan · Delayed Price · Currency is TWD 166.50
-2.50 (-1.48%)
Jan 21, 2026, 2:59 PM CST
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 14.25 billion as of January 21, 2026. Its market cap has increased by 239.77% in one year.
Market Cap
14.25B
Enterprise Value
13.04B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
166.50
Market Cap Chart
Since July 14, 2023, AP Biosciences's market cap has increased from 5.10B to 14.25B, an increase of 179.61%. That is a compound annual growth rate of 50.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 14.25B | -7.00% |
| Dec 31, 2025 | 15.32B | 262.77% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
| Jul 14, 2023 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 254.20B |
| PharmaEssentia | 215.25B |
| Lotus Pharmaceutical | 84.02B |
| Heron Neutron Medical | 69.72B |
| Bora Pharmaceuticals Co., LTD. | 64.74B |
| Oneness Biotech | 33.97B |
| Center Laboratories | 31.09B |
| Lin BioScience | 30.77B |